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TBC1 domain family member 1 (TBC1D1), a Rab GTPase-
activating protein and paralogue of Akt substrate of 160 kDa
(AS160), has been implicated in both insulin- and 5-aminoim-
idazole-4-carboxamide ribonucleotide formyltransferase/IMP
cyclohydrolase-mediated glucose transporter type 4 (GLUT4)
translocation.However, the role ofTBC1D1 in contractingmus-
cle remains ambiguous. We therefore explored the metabolic
consequence of ablating TBC1D1 in both resting and con-
tracting skeletal muscles, utilizing a rat TBC1D1 KO model.
Although insulin administration rapidly increased (p < 0.05)
plasma membrane GLUT4 content in both red and white gas-
trocnemius muscles, the TBC1D1 ablation did not alter this
response nor did it affect whole-body insulin tolerance, suggest-
ing that TBC1D1 is not required for insulin-induced GLUT4
trafficking events. Consistent with findings in other models of
altered TBC1D1 protein levels, whole-animal and ex vivo skele-
tal muscle fat oxidation was increased in the TBC1D1 KO rats.
Although there was no change in mitochondrial content in the
KO rats, maximal ADP-stimulated respiration was higher in
permeabilized muscle fibers, which may contribute to the
increased reliance on fatty acids in resting KO animals. Despite
this increase in mitochondrial oxidative capacity, run time to
exhaustion at various intensities was impaired in the KO
rats. Moreover, contraction-induced increases in sarcolemmal
GLUT4 content and glucose uptake were lower in the white gas-
trocnemius of the KO animals. Altogether, our results highlight
a critical role forTBC1D1 in exercise tolerance and contraction-
mediated translocation of GLUT4 to the plasma membrane in
skeletal muscle.
Skeletal muscle glucose uptake in response to either insulin
or contraction is a highly regulated process that results in facil-
itated diffusion through glucose transporter 4 (GLUT4).3 The
effects of these metabolic stimuli are additive (1, 2), ultimately
resulting in the translocation of GLUT4 from intracellular
depots to the sarcolemmal membrane. Akt2 (also known as
protein kinase B (PKB)) is a proximal member of the insulin
signaling cascade, and its phosphorylation is an essential step in
insulin-stimulated glucose transport (3), whereas contraction-
mediated translocation of GLUT4 is believed to occur via a
distinct molecular mechanism (2, 4–7). Although the terminal
downstream factors of both of these cascades are currently not
fully understood, the binding of Rab-GTPases to GLUT4-con-
taining vesicles is thought to be critical for translocation in both
processes (8).
Rab GTPase-activating proteins (GAPs) are members of the
Ras superfamily ofmonomericG-proteins that regulate numer-
ous membrane trafficking events, including vesicle formation
and movement along actin and tubulin networks, as well as
membrane fusion. Two protein members of the TBC1 (Tre-2,
BUB2, CDC16) domain family member 1 (TBC1D1) and
TBC1D4 (also known as AS160) are functional GAPs that are
believed to prevent GLUT4 translocation by maintaining Rabs
in their inactive GDP-bound state (8). Although AS160 and
TBC1D1 are only 61% similar in sequence over their entire
length, their Rab GAP domains are 91% similar and have the
same Rab substrate specificity (9). Upstream intracellular sig-
naling events (e.g. insulin stimulation or contraction) result in
the phosphorylation of AS160 and TBC1D1 and binding of
these proteins to the molecular adaptor protein 14-3-3. Ulti-
mately, these events enable GAPs to return to an active GTP-
bound state and initiate vesicle exocytosis and trafficking of
GLUT4 transporters (8).
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Work in cell lines has shown that deletion of TBC1D1
increases GLUT4 translocation to the plasma membrane
(10), whereas overexpression inhibits it (9, 11), further support-
ing the notion that TBC1D1 plays a role in the control of
GLUT4 translocation. Paradoxically, results in animals lacking
TBC1D1 show no difference in whole-body glucose or insulin
tolerance, whereas in vivo maximal insulin-stimulated skeletal
muscle glucose uptake is impaired (12, 13), which is contradic-
tory to the proposed mechanism of action for this protein in
glucose handling and GLUT4 trafficking. However, both
congenic mice lacking TBC1D1 (12) and conventional
TBC1D1 knock-out (KO) mice (13, 14) display an 50%
reduction in total GLUT4 protein, which by itself has been
shown to impair in vitro glucose uptake without altering
whole-body glucose tolerance (15). Therefore, one possi-
ble explanation for the decrease in glucose transport in
TBC1D1-deficient mice is the decrease in GLUT4 protein
content, making interpretations on the functional role of
TBC1D1 with respect to intracellular trafficking difficult.
Nevertheless, the decreased GLUT4 content suggests that
TBC1D1 influences glucose homeostasis and may represent
a compensatory attempt by the cell to maintain glucose
homeostasis and limit glucose flux into the muscle.
More recently, work in both rodents (16–18) and humans
(17, 19) has shown that TBC1D1 may play a critical role in the
signaling cascade in response to skeletal muscle contraction
with TBC1D1 a downstream target of 5-AMP-activated pro-
tein kinase (AMPK). Contraction, but not insulin stimulation,
has been shown to increase binding of 14-3-3 to TBC1D1 in an
AMPK-dependent manner in both rodents (16) and humans
(17), a process that has been shown to be critical in the regula-
tionofGLUT4traffickingbyAS160(20,21).Furthermore,phos-
phorylation of TBC1D1 viaAMPK leads to a greater decrease in
electrophoretic mobility compared with Akt, suggesting that
AMPK is a more robust regulator of this protein than insulin
(18).
Although the precise role of TBC1D1 in glucose transport
appears uncertain, one consistent finding among cell and ani-
mal studies is its effect on lipid oxidation. Several models have
shown alterations in lipid oxidation as a result of TBC1D1 defi-
ciency. Specifically, TBC1D1 ablation in vitro and in vivo
increases fatty acid oxidation (13, 22), and conversely, overex-
pression of TBC1D1 reduces skeletal muscle palmitate oxida-
tion (22, 23) and -hydroxyacyl-CoA dehydrogenase (-HAD)
activity (23). However, the mechanism of action resulting in
up-regulated fatty acid oxidation remains unknown. The fatty
acid transporter FAT/CD36 has been shown to translocate in
response to both insulin and contraction (24) and is critical in
the regulation of skeletalmuscle fuel selection (25), butwhether
this occurs via a vesicle-dependent mechanism involving
TBC1D1 remains to be determined.
Altogether, state-of-the art studies have provided compelling
evidence that TBC1D1 ablation impairs glucose uptake and
increases fatty acid oxidation. However, the current KOmouse
models display a marked reduction in GLUT4 content, which
by itself may also convey a similar phenotype (i.e. impaired glu-
cose uptake, greater reliance on fatty acids, and impairment in
exercise capacity), making interpretations difficult. Therefore,
we aimed to characterize the role of TBC1D1 in a previously
unexaminedKO ratmodel that lacks a compensatory reduction
in GLUT4 content. Using this model, we provide evidence
that TBC1D1 regulates contraction but not insulin-mediated
GLUT4 translocation in glycolytic muscles and subsequently
decreases exercise capacity. These results appear specific to
GLUT4 as FAT/CD36 trafficking was not altered. Taken
together, these results provide support for a role of TBC1D1 in
intracellular GLUT4 trafficking in response to contraction but
not insulin stimulation.
Results
Tissue screen and animal characterization
We first characterized TBC1D1 KO animals to determine
whether they displayed phenotypic differences compared with
wild-type (WT) animals (Table 1). There were no differences in
animalor tissueweightsor inheart sizenormalized to tibial length.
TBC1D1deficiencywas confirmedby screening forTBC1D1pro-
tein in skeletal muscle homogenate. KO animals did not express
TBC1D1protein in redorwhitemuscle; however, theyhad similar
levels of AS160, Akt2, and FAT/CD36 (Fig. 1A). We also assessed
GLUT4 protein content, which was not different compared with
WT rats in red or white muscle (Fig. 1, B andC).
Skeletal muscle response to insulin
Given the unaltered GLUT4 content in this KO model and
the proposed role of TBC1D1 in glucose homeostasis, we first
examined the effect of ablating this protein on glucose handling
at the whole-body level. In support of previous work demon-
strating that TBC1D1 influences beta cell mass/stability (26,
27), TBC1D1KO animals displayed impaired glucose clearance
during an intraperitoneal glucose tolerance test (GTT) (Fig. 2A)
as demonstrated by an increase in the area under the curve (p
0.05; Fig. 2B). However, there was no difference between
TBC1D1WTandKOanimals during an intraperitoneal insulin
tolerance test (ITT), suggesting that peripheral insulin sensitiv-
ity is intact in this model (Fig. 2, C and D). Consistent with
similarwhole-bodyinsulinsensitivity,insulinincreasedthephos-
phorylation of Akt2 by3-fold in both red and white muscles
in both WT and KO animals (Fig. 3, A and B). Total muscle
Table 1
Animal characterization and tissue screen of WT and TBC1D1 KO animals
The data are expressed as meansS.E. (error bars) (n 3–5). WAT, white adipose tissue.
Genotype
Animal characteristic
Weight Soleus EDL Heart Heart/tibial length Liver WAT
g g g g gcm1 g g
WT 409.80 13.42 0.195 0.04 0.170 0.01 1.09 0.03 0.249 0.01 9.48 0.78 5.89 0.39
KO 353.80 40.52 0.167 0.01 0.155 0.01 1.10 0.09 0.254 0.02 9.69 1.06 6.34 1.28
TBC1D1 is required for contraction-induced GLUT4 trafficking
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GLUT4 expression and insulin-mediated GLUT4 trafficking in
giant sarcolemmal vesicles was also unaltered between geno-
types (Fig. 3, C and D). Collectively, these data suggest that
TBC1D1 is not required for insulin-stimulated glucose uptake
in skeletal muscle.
Substrate utilization
As alterations in TBC1D1 protein have been associated with
changes in fat metabolism, we next examined fuel utilization in
vivo. In the present study and consistent with previous reports
in murine models (13, 22), TBC1D1 KO rats displayed a
Figure1. Tissue screen for variousprotein targets (A) andquantifiedGLUT4protein content in skeletalmusclehomogenate (BandC) (n6). Thedata
are expressed as means S.E. (error bars). RG, red gastrocnemius;WG, white gastrocnemius.
Figure 2. TBC1D1 animals display impaired glucose tolerance.Glucose levels during an intraperitoneal glucose (A) or insulin (C) tolerance test are shown.
Area under the curve (AUC) during glucose (B) and insulin (D) tolerance tests was calculated forWT and KO animals (n 5). The data are expressed asmeans
S.E. M. (error bars). *, p 0.05; **, p 0.01; †, p 0.001 versusWT.
TBC1D1 is required for contraction-induced GLUT4 trafficking
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decreased respiratory exchange ratio (RER), and therefore cal-
culated fat oxidation was increased whereas carbohydrate oxi-
dation was concomitantly decreased in both the light and dark
cycle (Fig. 4, A–C; p 0.05). These responses represent a shift
in fuel preference as there was no change in total energy
expenditure (Fig. 4D). The increase in fatty acid oxidation was
also observed in ex vivo experiments in isolated EDL muscle
strips. Specifically, palmitate oxidation was increased by 36%
(Fig. 4E; p 0.05). In contrast, there was no change in glucose
oxidation (Fig. 4F) in KO animals.
Mitochondrial respiration
Given this alteration in skeletal muscle fatty acid oxidation,
we next examined whether the KO animals displayed a change
in mitochondrial content or respiratory function. TBC1D1 KO
animals displayed increasedADP-stimulated oxygen consump-
tion in permeabilized muscle fibers (Fig. 5A; p  0.05); how-
ever, there was no change in lipid-supported respiration
(palmitoyl-CoA (P-CoA); Fig. 5A, right y axis). To determine
whether this functional increase was due to a change in mito-
chondrial protein content, we digested the fibers used for oxy-
gen consumption measurements for assessment via Western
blotting. Similar to previous work in TBC1D1 KO mice (14),
mitochondrial content in both digested fibers (Fig. 5B) and
muscle homogenate (Fig. 5, C and D) was similar between WT
and KO animals. Furthermore, there was no difference in
basal -HAD enzyme activity in white (WT, 5.10  1.04
molmin1g1 wet weight; KO, 4.33 0.63 molmin1g1
wet weight; n  6, p  0.30) or red muscle (WT, 14.56  1.77
molmin1g1 wet weight; KO, 13.95  1.37 mol
min1g1 wet weight; n 6, p 0.77) between genotypes. To
further examine the effects of ablating TBC1D1 on oxidative
phosphorylation, we determined the kinetic properties of ADP
to stimulate respiration in the presence of saturating substrates
(Fig. 6,A andC).Maximal respirationwas higher inKOanimals
when ADP was titrated both with and without creatine (37%,
p 0.05 versusWT; Fig. 6,A andC, respectively); however, this
did not alter estimatedADP sensitivity as assessed by the appar-
ent Km (Fig. 6, B andD, respectively). Similarly, maximal respi-
ration in KO animals was also increased (30%, p 0.05) when
pyruvate was titrated in the presence of saturating ADP con-
centrations with no effect on the apparent Km (Fig. 6, E and F).
Skeletal muscle contraction
We next sought to determine whether the up-regulation of
fatty acid oxidation seen at both the whole-body and skeletal
muscle levels in KO animals could be explained by altered sub-
strate delivery and/ormetabolic inflexibility in response to con-
traction. Following electrical stimulation, AMPK and ACC
were phosphorylated regardless of genotype ormuscle (Fig. 7,A
and B), confirming successful contraction of the muscles and
suggesting that these signaling cascades remained intact in the
absence of TBC1D1. We therefore isolated giant sarcolemmal
vesicles for the determination of plasma membrane transport-
Figure 3. GLUT4 translocation in response to insulin. Basal and insulin stimulated phosphorylated Akt (Ser-473) protein content in red (A) and white (B)
gastrocnemius muscle. Basal and insulin stimulated plasma membrane GLUT4 in (C) red and (D) white gastrocnemius muscle. Ponceau staining of the
membranewas used as a loading control. The data are expressed asmeans S.E. M. (error bars). *, p 0.05,main effect versusbasal. pAkt, phosphorylated Akt;
tAkt, total Akt.
TBC1D1 is required for contraction-induced GLUT4 trafficking
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ers. Although FAT/CD36 increased in red muscle following
contraction (Fig. 7C), there was no difference between geno-
types and no effect of contraction in either group in white mus-
cle (Fig. 7D). This suggests that the increase inwhole-body fatty
acid oxidation in KO animals is not due to increased transport
into skeletal muscle. We next sought to determine whether
Figure 4. TBC1D1 KO animals display an increased reliance on fatty acid oxidation. Indirect calorimetry measurements of (A) RER, (B) fat oxidation, (C)
carbohydrate oxidation and total energy expenditure (D) were determined in light and dark cycles forWT or KO animals (n 8). (E) Palmitate oxidation and (F)
glucose oxidation in EDL strips (n5). The data are expressed as means S.E. M. (error bars). *, p 0.05 versusWT.
Figure5. TBC1D1KOanimalsdisplay improvedmitochondrial function.A,mitochondrial oxygen consumption inpermeabilized fibers prepared fromEDL
muscle. Mitochondrial respiration was determined in the absence (state 4) and presence of ADP (5mM; state 3) supported by complex I (pyruvatemalate
glutamate; 5 mM each), complex II (succinate; 10mM), and lipid-supported (P-CoA; 60M) substrates. Uncoupled respiration wasmeasured in the presence of
2,4-dinitrophenol (50 M). Respiratory control ratios (state 3/state 4) were calculated at5.9 for WT and7.3 for TBC1D1 KO rat fibers bundles. B, represen-
tative digested fiber blot for mitochondrial subunits of the electron transport chain. Mitochondrial content in red and white gastrocnemius muscles was
determined by an OXPHOS antibody, which recognizes subunits of the electron transport chain complexes (CI–CV) (C), and a representative blot is shown (D).
The data are expressed as means S.E. M. (error bars) (n 8). *, p 0.05 versusWT. P, pyruvate;M, malate; D, ADP; G, glutamate; S, succinate.
TBC1D1 is required for contraction-induced GLUT4 trafficking
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there was an impairment in contraction-mediated glucose
uptake andGLUT4 trafficking. Electrically induced contraction
resulted in a significant increase in 2-deoxyglucose (2-DG)
uptake in both genotypes in red and white muscles (p  0.05;
Fig. 8, A and B); however, compared with WT, this effect was
significantly reduced in KO animals in white muscle (p 0.05;
Fig. 8B). The increase in glucose uptake from basal levels (	
change) following stimulation was also significantly reduced in
whitemuscle (p 0.05; Fig. 8A, inset) and tended to be lower in
red muscle (p  0.07; Fig. 8B, inset) of KO animals. These
effects were mirrored in sarcolemmal GLUT4 protein content
as there was amain effect for contraction to increase GLUT4 in
red muscle with a strong trend for a decreased response to
contraction inKOanimals (p 0.10; Fig. 8C, inset). In addition,
both absolute plasma membrane GLUT4 content and the abil-
ity of contraction to stimulate plasma membrane GLUT4 con-
tent were lower in white muscle of KO animals following con-
traction (Fig. 8,D and inset), further suggesting that ablation of
TBC1D1 impairs intracellular trafficking and glucose uptake.
Given this finding, we analyzed glycogen utilization during
contraction to determine whether there was a compensatory
increase in endogenous substrate utilization. However, there
wasnochange inglycogencontentor inskeletalmusclemetabolite
production (Table 2) between genotypes following contraction.
Time to exhaustion
Given our finding of reduced GLUT4 trafficking and glucose
uptake in KO animals in response to contraction and the prom-
inent role of exogenous substrates during contraction in rats,
we next examined whether this would result in impaired
running performance. Consistent with reductions in glucose
uptake in situ, running time decreased in TBC1D1 KO animals
by 18% at low intensity and 25% at the higher intensity
(Fig. 9).
Figure 6. Kinetic properties of mitochondria. Shown are ADP titrations in permeabilized fibers prepared from EDL muscle in the presence (A and B) and
absence (C and D) of creatine with pyruvate and malate present in the respiration buffer. Pyruvate titrations (E and F) were performed with ADP and malate
present in the buffer. The data are expressed as means S.E. M. (error bars) (n 8). *, p 0.05 versusWT.
TBC1D1 is required for contraction-induced GLUT4 trafficking
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Discussion
In this study, we utilized a novel TBC1D1 KO rat model to
elucidate the role of this protein in intracellular GLUT4 traf-
ficking. We have shown that, in contrast to the TBC1D1-defi-
cient murine model, there is no decrease in total GLUT4 pro-
tein content or impairment in GLUT4 accumulation on the
plasma membrane of muscle in response to insulin. These data
therefore suggest that TBC1D1 is not required for insulin-me-
diatedGLUT4 trafficking. In contrast, we provide evidence that
contraction-mediated glucose uptake and GLUT4 transloca-
tion in KO animals are impaired in TBC1D1 KO animals, and
this is associated with compromised exercise capacity. These
findings demonstrate that TBC1D1 plays an important role
in contraction-mediated but not insulin-stimulated GLUT4
translocation in skeletal muscle.
TBC1D1 KO animals display intact insulin signaling
In the current study, we have shown that TBC1D1 ablation
results in impaired glucose tolerance, which is consistent with
previous reports implicating this protein in maintaining beta
cellmass (26, 27).However, the currentwork also demonstrates
that TBC1D1 is not required for intracellular GLUT4 traffick-
ing in response to insulin as there were no differences in ITT or
in total or phosphorylated (Ser-473) Akt2 or plasmamembrane
GLUT4 content. Our findings are supported by previous work
showing that mutation of the canonical Akt phosphorylation
motif on TBC1D1 (Thr-596) to Ala had no effect on insulin-
stimulated glucose transport (28). We have also shown that
total GLUT4 protein is unaltered between WT and KO rats,
which is critical to the interpretations of the functional role
of TBC1D1. This is in contrast to previous work utilizing
TBC1D1-deficient mice that showed impaired insulin-stimu-
lated glucose transport (12, 13). However, these studies were
confounded by an 50% reduction in GLUT4 content, thus
making it difficult to ascertain the exact role of TBC1D1 in
glucose transport. It is therefore possible that the reduced glu-
cose uptake in TBC1D1-deficient mouse models is a conse-
quence of loweredGLUT4 content as opposed to a direct role of
TBC1D1 in mediating GLUT4 trafficking.
Figure 7. AMPK signaling and FAT/CD36 translocation in response to contraction. Total (tAMPK) and phosphorylated AMPK (pAMPK) and total (tACC) and
phosphorylatedACC (pACC) in skeletalmusclehomogenate fromred (A) andwhite (B) gastrocnemiusmuscles in response toelectrical stimulation (Stim) of the sciatic
nerve isunaltered inTBC1D1KOanimals (n4).PlasmamembraneFAT/CD36wasmeasured ingiantsarcolemmalvesicles isolatedfromred(C) andwhite (D)muscles
(n 6). Ponceau staining of themembranewas used as a loading control. The data are expressed asmeans S.E.M. (error bars). *, p 0.05 versus basal.
TBC1D1 is required for contraction-induced GLUT4 trafficking
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Figure 8. 2-DGuptake andGLUT4 translocation in response to contraction. 2-DGuptake in red (A) andwhite (B) gastrocnemius inWT andKOanimals (n
8 forWT and n 5 for KO) is shown. Plasmamembrane GLUT4wasmeasured in giant sarcolemmal vesicles isolated from red (C) andwhite (D) gastrocnemius
muscles (n 6) in response to electrical stimulation (Stim) of the sciatic nerve. The insets within each figure depict the absolute changes (	) in response to
contraction (i.e. contraction minus sedentary). Ponceau staining of the membrane was used as a loading control. The data are expressed as means S.E. M.
(error bars). *, p 0.05 versus basal; †, p 0.05 versusWT stimulated (Stim).
Table 2
Skeletal metabolite content in red and white gastrocnemius muscle following electrical stimulation of the sciatic nerve
The data are expressed as meansS.E. (error bars) (n 6). Cr, creatine; Stim, stimulated.
Metabolites
Red muscle White muscle
Control Stim Control Stim
WT KO WT KO WT KO WT KO
ATP (mmolkg1 dry wt) 24.87 0.87 25.66 1.41 22.41 1.32 25.31 0.61 28.27 2.24 27.99 0.76 28.95 1.98 28.66 1.01
PCr (mmolkg1 dry wt) 68.4 3.4 69.5 5.9 58.4 3.9 64.5 4.1 82.4 7.1 81.9 2.1 61.7 6.5a 65.7 7.0a
Cr (mmolkg1 dry wt) 57.5 2.7 61.9 3.6 55.5 2.5 63.6 4.1 64.5 4.7 69.8 3.7 85.2 10.2a 97.2 13.4a
Total Cr (mmolkg1 dry wt) 125.9 4.9 131.3 6.5 113.9 5.9 128 4.24 146.9 8.5 151.7 2.4 147.0 13.2 162.9 7.9
Lactate (mmolkg1 dry wt) 2.3 0.3 2.7 0.7 4.1 1.2 3.27 0.5 5.3 1.1 5.6 0.4 10.6 1.8a 17.7 5.0a
Glycogen (mmolkg1 dry wt) 111.24 19.36 114.85 24.38 50.58 6.78a 60.90 10.43a 96.03 13.88 106.32 10.57 40.32 11.46a 50.13 11.35a
a p 0.05, main effect versus control.
TBC1D1 is required for contraction-induced GLUT4 trafficking
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Increased fatty acid oxidation in TBC1D1 KO animals
We have shown that ablation of TBC1D1 resulted in an
increase in whole-body fat oxidation, which occurred in the
absence of any change in energy expenditure. This is consistent
with previous studies utilizing TBC1D1-deficient mice (13, 22)
as well as cell line models with reduced TBC1D1 (22). We have
also shown an increase in palmitate oxidation in KO animals in
isolated EDL strips; however, there was no change in glucose
oxidation between genotypes. This suggests that, in the absence
of other substrates, the ability to utilize fatty acids is increased
in TBC1D1 KO animals, whereas the basal capacity to oxidize
carbohydrate is not impaired.
To elucidate the mechanisms underlying the change in sub-
strate utilization, we evaluated a proximal step in lipid oxida-
tion, FAT/CD36 trafficking to the plasma membrane. FAT/
CD36 has previously been shown to respond to similar
metabolic stimuli as GLUT4, including insulin and skeletal
muscle contraction (24), and is a key component for the regu-
lation of skeletal muscle fuel selection (25). It was therefore
possible that TBC1D1 plays an important role in intracellular
trafficking of this transporter and that ablation of the TBC1D1
gene would result in a compensatory increase in localization of
FAT/CD36 to the plasma membrane. However, there was no
difference between KO andWT animals in FAT/CD36 protein
contentmeasured in sarcolemmal vesicles at rest (p 0.45) and
following contraction in red or white muscle. This therefore
indicates that increases in fatty acid transport cannot explain
the shift in fuel selection in these animals.
Previous work utilizing TBC1D1 overexpression in mice
showed reduced activity of -HAD concomitant with a
decrease in fatty acid oxidation (23). However, neither -HAD
activity nor rates of P-CoA supported mitochondrial respira-
tion were altered in KO rats and therefore cannot explain the
observed increase in fatty acid oxidation seen at the whole-
body or muscle level. In contrast, TBC1D1 KO animals display
increased mitochondrial respiration in the absence of any
change in mitochondrial protein content, suggesting improved
respiratory function. This cannot be explained by increased
sensitivity to substrates as there was no change in the apparent
Km for pyruvate or for ADP either in the presence or absence of
creatine. It is therefore possible that the increase in mitochon-
drial function is a compensatory adaptation in response to
TBC1D1 ablation; however, further work is required to eluci-
date the exact mechanism behind this. An increase in maximal
mitochondrial respiration supports our finding of increased
reliance on fatty acid oxidation and may indicate tighter meta-
bolic control as increased respiration, and therefore ATP pro-
duction, should result in decreased accumulation of mitochon-
drial-free ADP, although this remains speculative and requires
further examination.
Impaired contraction-mediated GLUT4 translocation
Consistent with previous reports, we have shown that run
time to exhaustion is impaired in TBC1D1 KO animals (14).
However, in the previous study, total GLUT4 protein was
decreased, again making it difficult to determine whether the
impairment in exercise capacity was due to a decrease in trans-
porter protein content or the ablation of TBC1D1. In the cur-
rent study, we have shown that total GLUT4 protein content
was not reduced in the KO animals, and therefore the exercise
impairment is likely a result of decreased contraction-mediated
GLUT4 trafficking and therefore decreased glucose uptake.
This clearly highlights TBC1D1 as having a critical role in
glucose homeostasis during exercise, especially given the
increased reliance on exogenous glucose as a fuel source in
rodents. Interestingly, the decrease in contraction-mediated
glucose uptake and plasma membrane GLUT4 content did not
result in increased intramuscular glycogen breakdown or an
increase in cellular energy perturbation as measured by metab-
olite accumulation. This suggests that despite the apparent
improvement in mitochondrial respiratory function TBC1D1
KO animals are not able to adequately compensate for the
decrease in glucose uptake to rescue exercise capacity.
Conclusion
Altogether, we have shown that TBC1D1 KO rats displayed
increased mitochondrial respiratory function, which may
explain the increase in fatty acid oxidation seen both ex vivo and
at the whole-body level. Despite these alterations, KO animals
displayed decreased exercise capacity likely due to the decrease
in GLUT4 translocation and glucose uptake seen following
contraction. Combined with the findings that TBC1D1 expres-
sion is highly specific to skeletal muscle (11, 18) and appears to
bemore robustly regulated byAMPK thanAkt-mediated phos-
phorylation (18), these results support the theory that TBC1D1
is downstream of AMPK and represents a likely terminus for
the contraction-mediated signaling cascade responsible for
GLUT4 translocation.
Experimental procedures
Chemicals
All chemicals were purchased from Sigma-Aldrich unless
stated otherwise.
Figure 9. Impaired exercise capacity in TBC1D1 KO animals. Time to
exhaustion (min) in WT and TBC1D1 KO animals during treadmill running at
low (LO; 20 mmin1, 5% grade) and high (HI; 20 mmin1, 15% grade) inten-
sities. ThedataareexpressedasmeansS.E. M. (error bars) (n6). *,p0.05,
main effect for intensity and genotype.
TBC1D1 is required for contraction-induced GLUT4 trafficking
J. Biol. Chem. (2017) 292(40) 16653–16664 16661
 at U
niv of G
uelph - O
CU
L on O
ctober 15, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Rodents
TBC1D1 KO rats on a Sprague-Dawley background were
provided by Dr. Hamra (29). Animals were housed in a temper-
ature- and humidity-regulated room on a 12/12-h light–dark
cycle. Rats were maintained on a chow diet (Harlan Laborato-
ries Inc.) with ad libitum access to food andwater. All protocols
were approved by and performed in accordance with the Com-
mittee on Animal Care guidelines at the University of Guelph.
Glucose and insulin tolerance tests
Four-hour-fasted rats underwent intraperitoneal GTT (2
g/kg of body weight) and ITT (1 unit/kg of body weight; Humu-
lin, Lilly) tolerance tests. Blood glucose was measured using a
glucose meter (Freestyle Lite, Abbott Diabetes Care) for both
GTT and ITT before and up to 120 and 45 min post-injection,
respectively.
Indirect calorimetry
Oxygen consumption (VO2), carbon dioxide (VCO2), and
RER were measured over a 24-h period in a CLAMS (Compre-
hensive Laboratory Animal Monitoring System) open circuit
system (Columbus Instruments). Fat and carbohydrate oxida-
tion and total energy expenditure were calculated as described
previously (30).
Substrate oxidation
To determine the rates of substrate oxidation, glucose and
palmitate oxidation assays were performed in EDL muscle
strips as described previously (31, 32). Briefly, palmitate oxida-
tion was measured in pregassed (95% O2, 5% CO2) modified
Krebs-Henseleit buffer supplemented with 4% BSA and palmi-
tate (0.5 mM; 0.5 Ci/l [1-14C]palmitate) (PerkinElmer Life
Sciences) at 30 °C for 40 min by measuring the 14CO2 released
in addition to determining the water-soluble 14C-labeled inter-
mediates. Glucose oxidationwas determined in a separate set of
experiments as described previously (33). Briefly, muscle strips
were incubated in modified Krebs-Henseleit buffer supple-
mented with 5.5 mM glucose and 0.2 Ci D-[U-14C]glucose
(American Radiolabeled Chemicals) at 30 °C for 40 min. Gase-
ous 14CO2 was captured as above and counted using standard
liquid scintillation techniques. Substrate oxidation rates were
calculated using the specific activity of labeled palmitate or glu-
cose within the Krebs-Henseleit buffer and normalized tomus-
cle weight.
Skeletal muscle response to insulin
To determine skeletal muscle-specific insulin signaling, rats
were anesthetized (sodium pentobarbital; 60 mg/kg of body
weight), and then muscle samples were excised before (basal)
and 30 min after an intravenous insulin injection (1 unit/kg of
body weight). Harvested tissues were collected for plasma
membrane preparations or rapidly frozen in liquid nitrogen for
Western blotting as described below.
Electrical stimulation-inducedmuscle contraction
For muscle contraction experiments, the sciatic nerve of the
experimental limb was exposed, and stimulating electrodes
were placed around the nerve. Electrical stimulation was
applied for 15 min (train delivery, 100 Hz/3 s at 6–8 V; train
duration, 200 ms; pulse duration, 10 ms). Following stimula-
tion, both experimental and control hind limbmuscles (red and
white gastrocnemius and red and white tibialis anterior) were
excised and either immediately frozen in liquid nitrogen for
further analysis or used for the preparation of giant sarcolem-
mal vesicles.
In vivo glucose clearance
Muscle-specific glucose uptake was performed by tail vain
injection. Specifically, 50 Ci of tritiated 2-DG was injected 5
min before commencing 15min of sciatic nerve stimulation (as
described above). Thereafter, muscle was immediately taken
and rates ofmuscle-specific glucose uptakewere determined by
analyzing radioactivity from red and white gastrocnemius as
described previously (31, 32).
Muscle enzymatic activity
Red and white tibialis anterior muscles were excised from
both experimental and control limbs following stimulation
experiments and immediately frozen in liquid nitrogen. A small
piece of frozenmuscle (6–10mg)was taken for the spectropho-
tometric determination of -HAD at 37 °C as described previ-
ously (33).
Glycogen andmetabolite analysis
Red and white gastrocnemius muscles from both the control
and experimental limb in stimulation experiments was freeze-
dried, dissected free of visible blood and connective tissue, and
powdered for metabolite and glycogen analyses. An aliquot of
freeze-dried muscle (10–12 mg) was extracted with 0.5 M per-
chloric acid (HClO4) containing 1 mM EDTA and neutralized
with 2.2 M KHCO3. The supernatant was used to determine
creatine, PCr, ATP, and lactate with enzymatic spectrophoto-
metric assays (33, 34). Muscle glycogen content was deter-
mined from an aliquot of freeze-dried muscle (2–3 mg) as
described elsewhere (33).
Isolation of plasmamembranes
Giant sarcolemmal vesicles were prepared as described pre-
viously (24). Briefly, red and white gastrocnemius muscles
excised following contraction and insulin stimulation experi-
ments were cut into thin strips and incubated (1 h, 34 °C, 100
rpm) in 140 mM KCl, 10 mM MOPS (pH 7.4) containing colla-
genase VII (150 units/ml) and aprotinin (10 mg/ml). The mus-
cle was washed with KCl/MOPS containing 10 mM Na2EDTA
(pH 7.4), and the supernatants were combined. Percoll (3.5%),
KCl (28mM), and aprotinin (10g/ml)were added to the super-
natant. This solution was layered under 3 ml of 4% Nycodenz
and 1ml of KCl/MOPS and centrifuged (60
 g, 45 min, 25 °C).
The vesicleswere harvested from the interface ofNycodenz and
KCl/MOPS and pelleted by centrifugation (9000 
 g, 10 min,
25 °C), and the resulting pellet was resuspended in KCl/MOPS
and stored at80 °C for Western blotting.
Preparation of permeabilized fibers
A small portion of muscle was placed in ice-cold BIOPS (50
mM MES, 7.23 mM K2EGTA, 2.77 mM CaK2EGTA, 20 mM im-
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idazole, 0.5mMDTT, 20mM taurine, 5.77mMATP, 15mMPCr,
and 6.56 mM MgCl2H2O (pH 7.1)) and separated under a
microscope into bundles using fine-tipped forceps as described
previously (35). Fiber bundles were then treated with 30 g/ml
saponin for 30min at 4 °C and thenwashed for 15min inMiR05
respiration buffer (0.5 mM EGTA, 10 mM HH2PO4, 110 mM
sucrose, 1 mg/ml fatty acid-free BSA (pH 7.1)) for respiration
analysis as described below.
Mitochondrial respiration
Measurements ofO2 consumptionwere performed inMiR05
respiration buffer on prepared permeabilized fibers using an
Oxygraph-2K (Oroboros Instruments, Innsbruck, Austria) at
37 °C in the presence of 25 M blebbistatin as described previ-
ously (36). ADP-stimulated respiration was determined in the
presence of 5 mM pyruvate and 2 mM malate as well as 60 M
P-CoA. Maximal state III respiration was determined by the
addition of 5 mM ADP with 10 mM glutamate and 10 mM suc-
cinate added to determine maximal complex I and maximal
complex I II respiration, respectively. Uncoupled respiration
was measured in the presence of 50 M 2,4-dinitrophenol.
Mitochondrial kinetics in permeabilized fibers were analyzed
using three separate titration protocols. ADPkineticswere ana-
lyzed both in the presence and absence of 20mM creatine. Both
ADP titrations were initiated with 2 mM malate and 10 mM
pyruvate, and ADP was titrated at various concentrations.
Pyruvate kinetics were determined in the presence of 5 mM
ADP, 5 mM malate, and 20 mM creatine, and pyruvate was
titrated in at various concentrations. Then 10 mM glutamate
and 10 mM succinate were added following the pyruvate and
ADP titrations to determine maximummitochondrial respira-
tion. Finally, 10 M cytochrome c was added with 10%
increase in respiration in all measurements indicating outer
mitochondrialmembrane integrity. The apparentKm values for
pyruvate and ADP were determined as described previously
(35). All fibers were recovered from the respirometer, freeze-
dried, and weighed for normalization to muscle bundle weight.
Freeze-dried fibers were then digested in 5 gl lysis buffer as
described previously (37) for determination of mitochondrial
proteins via Western blotting.
Western blotting
Whole muscle was homogenized in lysis buffer, diluted to 1
gl1, and loaded equally for TBC1D1 (Abcam), total and
phosphorylated (Ser-473) Akt2 (Cell Signaling Technology
Inc.), total and phosphorylated (Thr-178) AMPK (Cell Signal-
ing Technology Inc.), total and phosphorylated (Ser-79) ACC
(Cell Signaling Technology Inc.), GLUT4 (Chemicon), FAT/
CD36 (Santa Cruz Biotechnologies), MitoProfile Total OXPHOS
antibody mixture (Mitosciences), and cytochrome c oxidase
complex IV (Life Technologies) with both -tubulin (Abcam)
and Ponceau staining used as a loading control. Proteins were
separated by SDS-polyacrylamide gel electrophoresis, trans-
ferred to polyvinylidene difluoridemembrane, and incubated in
blocking solution, primary antibody, and the corresponding
secondary antibody as specified by the supplier. Membrane
proteins were detected by enhanced chemiluminescence
(ChemiGenius2 Bioimaging system, SynGene, Cambridge,
UK).
Time to exhaustion
Animals were familiarized to the treadmill at slow speeds (10
mmin1) for 3 consecutive days followed by a 48-h rest before
the start of the exercise bout. Animals completed a time to
exhaustion trial at two different intensities (low; 20 mmin1,
5% grade, and high, 20 mmin1, 15% grade) separated by
48 h.
Statistics
Results are expressed as means S.E. and were analyzed by
Student’s t test or one- or two-way analysis of variance with a
Fisher’s least significant difference post hoc test where appro-
priate. Significance was set at p 0.05 where NS indicates not
significant. All graphs and statistical analyses were performed
using GraphPad Prism 5.0 (GraphPad Software).
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